Top 20 Global Biopharma Companies See 2% Growth
The biopharmaceutical industry demonstrated signs of recovery in the third quarter (Q3) of 2024, with increased investor optimism following the interest rate cuts by the US Federal Reserve in September 2024. As a result, the top 20 global biopharmaceutical companies reported an upturn of 2% in aggregate market capitalization from $4.2 trillion as on 30 June 2024...
APAC deal volume dips 4.8% YoYÂ
A total of 11,808 deals (mergers & acquisitions (M&A), private equity and venture financing deals) were announced in the Asia-Pacific (APAC) region during January to October 2024, which was a year-on-year (YoY) decline of 4.8% compared to the 12,406 deals announced during the same period in 2023, according to GlobalData, a leading data and analytics company.
An analysis of GlobalData’s Deals Database revealed...
